Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_assertion type Assertion NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_head.
- NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_assertion description "[Thirty-six of 59 patients (61.0%) with esophageal cancer had detectable levels of methylated DAPK or APC promoter DNA and preoperative detection was significantly associated with an unfavorable prognosis as revealed by multivariate Cox proportional hazards regression analysis [Exp(b) = 4.578; P = 0.01].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_provenance.
- NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_assertion evidence source_evidence_literature NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_provenance.
- NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_assertion SIO_000772 19259700 NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_provenance.
- NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_assertion wasDerivedFrom befree-20150227 NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_provenance.
- NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_assertion wasGeneratedBy ECO_0000203 NP240549.RANpKCGXQuNhUjnWMrdDBIhAKGECFgSyk5ZtOnTMZ1CT8130_provenance.